Autonomix Medical (AMIX) & The Competition Critical Review

Autonomix Medical (NASDAQ:AMIX) is one of 237 public companies in the “Surgical & medical instruments” industry, but how does it weigh in compared to its competitors? We will compare Autonomix Medical to similar businesses based on the strength of its valuation, dividends, institutional ownership, risk, earnings, analyst recommendations and profitability.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Autonomix Medical and its competitors, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Autonomix Medical	0	0	1	0	3.00
Autonomix Medical Competitors	1904	4901	9169	268	2.48

Autonomix Medical currently has a consensus price target of $28.00, indicating a potential upside of 109.58%. As a group, “Surgical & medical instruments” companies have a potential upside of 18.49%. Given Autonomix Medical’s stronger consensus rating and higher possible upside, equities analysts clearly believe Autonomix Medical is more favorable than its competitors.

Valuation & Earnings

This table compares Autonomix Medical and its competitors top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Autonomix Medical	N/A	-$15.43 million	-0.83
Autonomix Medical Competitors	$1.01 billion	$10.43 million	-6.26

Autonomix Medical’s competitors have higher revenue and earnings than Autonomix Medical. Autonomix Medical is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares Autonomix Medical and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Autonomix Medical	N/A	-542.11%	-236.92%
Autonomix Medical Competitors	-570.81%	-156.88%	-27.81%

Insider and Institutional Ownership

10.8% of Autonomix Medical shares are held by institutional investors. Comparatively, 47.7% of shares of all “Surgical & medical instruments” companies are held by institutional investors. 32.4% of Autonomix Medical shares are held by company insiders. Comparatively, 15.3% of shares of all “Surgical & medical instruments” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

About Autonomix Medical

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.